セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 薬品事業 | 建材事業 |
|---|---|---|---|
| 売上高 | 2020/03 | 178億 -13.1% | 37.7億 +6.9% |
| 2021/03 | 162億 -8.8% | 34.6億 -8.2% | |
| 2022/03 | 198億 +22.3% | 39.3億 +13.5% | |
| 2023/03 | 201億 +1.6% | 39.6億 +0.8% | |
| 2024/03 | 185億 -7.8% | 39.1億 -1.4% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 営業利益 | 2020/03 | 19.1億 -20.9% | 10.8億 +9.2% |
| 2021/03 | 20.9億 +9.6% | 9.27億 -14.4% | |
| 2022/03 | 38.2億 +82.5% | 11.2億 +20.9% | |
| 2023/03 | 28億 -26.7% | 9.25億 -17.5% | |
| 2024/03 | 22.4億 -19.8% | 7.58億 -18% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 営業利益率 | 2020/03 | 10.8% -1% | 28.7% +0.6% |
| 2021/03 | 12.9% +2.1% | 26.8% -1.9% | |
| 2022/03 | 19.3% +6.4% | 28.5% +1.7% | |
| 2023/03 | 13.9% -5.4% | 23.3% -5.2% | |
| 2024/03 | 12.1% -1.8% | 19.4% -3.9% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 研究開発費 | 2020/03 | 400百万 +17% | 66百万 -16.5% |
| 2021/03 | 404百万 +1% | 72百万 +9.1% | |
| 2022/03 | 525百万 +30% | 76百万 +5.6% | |
| 2023/03 | 470百万 -10.5% | 60百万 -21.1% | |
| 2024/03 | 381百万 -18.9% | 72百万 +20% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 設備投資額 | 2020/03 | 18.1億 +37.9% | 193百万 +153.9% |
| 2021/03 | 5.5億 -69.7% | 60百万 -68.9% | |
| 2022/03 | 10.6億 +92.7% | 144百万 +140% | |
| 2023/03 | 8.16億 -23% | 155百万 +7.6% | |
| 2024/03 | 7.09億 -13.1% | 126百万 -18.7% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 固定資産増加額 | 2020/03 | 18.1億 +37.8% | 193百万 +153.1% |
| 2021/03 | 5.5億 -69.7% | 61百万 -68.4% | |
| 2022/03 | 10.6億 +92.7% | 144百万 +136.9% | |
| 2023/03 | 8.17億 -22.9% | 155百万 +7.7% | |
| 2024/03 | 6.94億 -15% | 127百万 -18.4% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 従業員数 | 2020/03 | 360 +2.3% | 51 ±0% |
| 2021/03 | 362 +0.6% | 54 +5.9% | |
| 2022/03 | 364 +0.6% | 57 +5.6% | |
| 2023/03 | 362 -0.5% | 56 -1.8% | |
| 2024/03 | 374 +3.3% | 51 -8.9% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 平均臨時雇用人員 | 2020/03 | 70 +2.9% | 46 ±0% |
| 2021/03 | 58 -17.1% | 47 +2.2% | |
| 2022/03 | 57 -1.7% | 49 +4.3% | |
| 2023/03 | 50 -12.3% | 51 +4.1% | |
| 2024/03 | 48 -4% | 49 -3.9% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 資産 | 2020/03 | 154億 -2.9% | 21.1億 +2.7% |
| 2021/03 | 153億 -0.6% | 20.7億 -1.9% | |
| 2022/03 | 172億 +12.6% | 24.3億 +17.5% | |
| 2023/03 | 170億 -1.3% | 25.5億 +5.2% | |
| 2024/03 | 172億 +1.2% | 24.8億 -3% | |
| 科目 | 年度 | 薬品事業 | 建材事業 |
| 減損損失 | 2020/03 | - | - |
| 2021/03 | - | - | |
| 2022/03 | 24百万 | - | |
| 2023/03 | 39百万 +61.1% | - | |
| 2024/03 | - | - |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 薬品事業 | ||||||
| 売上高 | 2020/03 | 46.6億 -12.8% | 44.3億 -13.8% | 46.5億 -15.2% | 40.1億 -10.1% | 178億 -13.1% |
| 2021/03 | 38.3億 -17.7% | 32.5億 -26.7% | 43.5億 -6.4% | 47.4億 +18.3% | 162億 -8.8% | |
| 2022/03 | 46.2億 +20.4% | 47億 +44.5% | 50.7億 +16.4% | 54.1億 +14% | 198億 +22.3% | |
| 2023/03 | 58.6億 +26.9% | 50.9億 +8.4% | 47.1億 -7% | 44.4億 -18% | 201億 +1.6% | |
| 2024/03 | 44.8億 -23.6% | 43.5億 -14.6% | 47.7億 +1.2% | 49.4億 +11.3% | 185億 -7.8% | |
| 営業利益 | 2020/03 | 5.37億 -25.3% | 3.59億 -35% | 6.32億 -8% | 3.81億 -16.2% | 19.1億 -20.9% |
| 2021/03 | 5.07億 -5.5% | 1.94億 -45.9% | 6.18億 -2.3% | 7.72億 +102.7% | 20.9億 +9.6% | |
| 2022/03 | 10.3億 +103% | 7.92億 +308% | 9.63億 +55.9% | 10.3億 +33.5% | 38.2億 +82.5% | |
| 2023/03 | 11.9億 +15.6% | 4.79億 -39.5% | 5.94億 -38.4% | 5.34億 -48.2% | 28億 -26.7% | |
| 2024/03 | 5.77億 -51.6% | 3.6億 -24.9% | 6.11億 +2.9% | 6.97億 +30.5% | 22.4億 -19.8% | |
| 営業利益率 | 2020/03 | 11.5% -2% | 8.1% -2.6% | 13.6% +1.1% | 9.5% -0.7% | 10.8% -1% |
| 2021/03 | 13.2% +1.7% | 6% -2.1% | 14.2% +0.6% | 16.3% +6.8% | 12.9% +2.1% | |
| 2022/03 | 22.3% +9.1% | 16.9% +10.9% | 19% +4.8% | 19.1% +2.8% | 19.3% +6.4% | |
| 2023/03 | 20.3% -2% | 9.4% -7.5% | 12.6% -6.4% | 12% -7.1% | 13.9% -5.4% | |
| 2024/03 | 12.9% -7.4% | 8.3% -1.1% | 12.8% +0.2% | 14.1% +2.1% | 12.1% -1.8% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 建材事業 | ||||||
| 売上高 | 2020/03 | 9.3億 +14.5% | 9.3億 +13.3% | 9.87億 +1.4% | 9.23億 +0.1% | 37.7億 +6.9% |
| 2021/03 | 8.53億 -8.2% | 7.85億 -15.6% | 9.61億 -2.6% | 8.63億 -6.5% | 34.6億 -8.2% | |
| 2022/03 | 9.06億 +6.2% | 9.46億 +20.5% | 11.1億 +15.1% | 9.73億 +12.7% | 39.3億 +13.5% | |
| 2023/03 | 9.42億 +4% | 9.84億 +4% | 10.4億 -6% | 9.98億 +2.6% | 39.6億 +0.8% | |
| 2024/03 | 10億 +6.7% | 9.73億 -1.1% | 10.4億 +0.4% | 8.86億 -11.2% | 39.1億 -1.4% | |
| 営業利益 | 2020/03 | 2.74億 +20.5% | 2.6億 +24.1% | 2.97億 -2.2% | 2.52億 +0.4% | 10.8億 +9.2% |
| 2021/03 | 2.35億 -14.2% | 2.05億 -21.3% | 2.7億 -9.1% | 2.18億 -13.7% | 9.27億 -14.4% | |
| 2022/03 | 2.53億 +7.4% | 2.75億 +34.5% | 3.52億 +30.4% | 2.42億 +11.1% | 11.2億 +20.9% | |
| 2023/03 | 2.36億 -6.8% | 2.43億 -11.8% | 2.65億 -24.6% | 1.81億 -25.1% | 9.25億 -17.5% | |
| 2024/03 | 2.2億 -6.8% | 1.89億 -22.1% | 2.2億 -17.2% | 1.3億 -28.4% | 7.58億 -18% | |
| 営業利益率 | 2020/03 | 29.5% +1.5% | 27.9% +2.4% | 30.1% -1.1% | 27.3% +0.1% | 28.7% +0.6% |
| 2021/03 | 27.6% -1.9% | 26.1% -1.8% | 28.1% -2% | 25.2% -2.1% | 26.8% -1.9% | |
| 2022/03 | 27.9% +0.3% | 29.1% +3% | 31.8% +3.7% | 24.9% -0.3% | 28.5% +1.7% | |
| 2023/03 | 25% -2.9% | 24.7% -4.4% | 25.5% -6.3% | 18.1% -6.8% | 23.3% -5.2% | |
| 2024/03 | 21.9% -3.1% | 19.4% -5.3% | 21% -4.5% | 14.6% -3.5% | 19.4% -3.9% | |